Project Grant R43HG012170
Award Date
8/17/21
Completion Date
2/28/22
Dollars Obligated
$765K
Federal Agency
National Human Genome Research Institute
Federal Grant Program
93.172
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This Project Grant award from the National Human Genome Research Institute (CFDA 93.172 - Human Genome Research) provides $383,482 to Electronic Biosciences, Inc. to develop the SPINSEQ platform, an innovative RNA sequencing technology. The goal is to create a highly precise and accurate solution for transcriptomic and epitranscriptomic analysis that can overcome the limitations of existing RNA sequencing methods. Key focus areas include maintaining RNA integrity, ensuring accurate sequencing,...
This Project Grant award from the National Human Genome Research Institute (NHGRI), under the Human Genome Research federal grant program (CFDA 93.172), will provide $215,088 to Directseq Biosciences, Inc. to develop an exhaustive de novo RNA sequencing method using next-generation mass spectrometry (NGMS-seq). The objective is to create a technology that can directly identify and sequence every RNA species in a sample, while also comprehensively profiling all RNA modifications, without bias....
This Project Grant award from the National Institute of General Medical Sciences (CFDA 93.859 Biomedical Research and Research Training program) provides $350,000 to Electronic Biosciences, Inc. to develop a novel technology for high-accuracy sequencing of pseudouridine (Ps) and N6-methyladenosine (M6A) RNA modifications. The project aims to merge Professor Cynthia J. Burrows' bisulfite adduct methodology with Electronic Biosciences' nanopore sequencing platform to create the first sequencing...
This Project Grant award from the National Human Genome Research Institute (NHGRI), under the Human Genome Research Federal Grant Program (CFDA 93.172), is funding the development of a novel epigenetic analysis method by Xgenomes Corp. The $397,599 award, granted on June 1, 2025, will enable Xgenomes to optimize the chemistry and validate their single-molecule platform for highly accurate detection of DNA methylation patterns across the genome. The project aims to overcome limitations of current...
The National Human Genome Research Institute (NHGRI), under the Human Genome Research Federal Grant Program (CFDA 93.172), awarded a $384,418 Project Grant to Xgenomes Corp. on September 25, 2024 to develop a revolutionary DNA sequencing platform. The project aims to create a super-resolution single-molecule sequencing technology that can read short sequence "words" rather than individual nucleotides, enabling one or more orders of magnitude improvements in accuracy and cost over...
This federal Project Grant award from the National Human Genome Research Institute (NHGRI), under the Human Genome Research CFDA program (93.172), provides $406,500 to Directseq Biosciences, Inc. to advance next-generation mass spectrometry-based sequencing (NGMS-SEQ) methods. The primary objectives are to 1) develop high-throughput NGMS-SEQ techniques for direct sequencing of transfer RNA (tRNA) samples, including physiologically relevant ones, and 2) enhance technologies to quantitatively...
The National Human Genome Research Institute (NHGRI), under the 93.172 Human Genome Research federal grant program, awarded a $3,377,867 Project Grant to Survey Genomics, Inc. on September 19, 2024. The grant supports the development and commercialization of the CytopeDrop platform, an innovative approach for spatially-resolved single-cell multiomics analysis. CytopeDrop enables researchers to simultaneously obtain mRNA abundances, protein abundances, and cell locations, providing crucial...
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research program (CFDA 93.866), provides $2,549,590 to Epicypher, Inc. to develop a novel approach called CUTANA-RH for genome-wide profiling of R-loops. R-loops are DNA-RNA hybrid structures implicated in aging and neurodegenerative diseases like Alzheimer's. The first innovation is a modular immunotethering strategy for mapping R-loops that uses a catalytically inactive RNase H1 enzyme instead of an unreliable...
The National Human Genome Research Institute (NHGRI) awarded a $594,501 Project Grant (CFDA 93.172 - Human Genome Research) to Cold Spring Harbor Laboratory to develop a unified probabilistic model and software implementation for analyzing nascent RNA sequencing data. The project aims to create powerful computational tools that can accelerate transcriptional research by enabling the estimation of transcriptional rates directly from nascent RNA sequencing data, with applications in areas such...
The National Institute on Aging (CFDA 93.866) awarded a $1,274,993 Project Grant to Epicypher, Inc. to develop a new approach called Reverse Transcribe & Tagmentation (RT & TAG) for identifying chromatin-associated RNAs (CARNAs), including nascent RNA transcripts, to accelerate aging and Alzheimer's disease/age-related dementia (AD/ADRD) research. The central innovation is an immunotethering-based method for in situ targeted tagmentation of CARNAs. The project also involves developing...